Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Department of General Thoracic Surgery, Showa General Hospital, Tokyo, Japan.
Eur J Cardiothorac Surg. 2024 May 3;65(5). doi: 10.1093/ejcts/ezae142.
Evaluating the diffusing capacity for carbon monoxide (DLco) is crucial for patients with lung cancer and interstitial lung disease. However, the clinical significance of assessing exercise oxygen desaturation (EOD) remains unclear.
We retrospectively analysed 186 consecutive patients with interstitial lung disease who underwent lobectomy for non-small-cell lung cancer. EOD was assessed using the two-flight test (TFT), with TFT positivity defined as ≥5% SpO2 reduction. We investigated the impact of EOD and predicted postoperative (ppo)%DLco on postoperative complications and prognosis.
A total of 106 (57%) patients were identified as TFT-positive, and 58 (31%) patients had ppo% DLco < 30%. Pulmonary complications were significantly more prevalent in TFT-positive patients than in TFT-negative patients (52% vs 19%, P < 0.001), and multivariable analysis revealed that TFT-positivity was an independent risk factor (odds ratio 3.46, 95% confidence interval 1.70-7.07, P < 0.001), whereas ppo%DLco was not (P = 0.09). In terms of long-term outcomes, both TFT positivity and ppo%DLco < 30% independently predicted overall survival. We divided the patients into 4 groups based on TFT positivity and ppo%DLco status. TFT-positive patients with ppo%DLco < 30% exhibited the significantly lowest 5-year overall survival among the 4 groups: ppo%DLco ≥ 30% and TFT-negative, 54.2%; ppo%DLco < 30% and TFT-negative, 68.8%; ppo%DLco ≥ 30% and TFT-positive, 38.1%; and ppo%DLco < 30% and TFT-positive, 16.7% (P = 0.001).
Incorporating EOD evaluation was useful for predicting postoperative complications and survival outcomes in patients with lung cancer and interstitial lung disease.
评估一氧化碳弥散量(DLco)对肺癌和间质性肺疾病患者至关重要。然而,评估运动性血氧饱和度下降(EOD)的临床意义尚不清楚。
我们回顾性分析了 186 例因非小细胞肺癌行肺叶切除术的间质性肺疾病患者。使用双飞行试验(TFT)评估 EOD,TFT 阳性定义为 SpO2 下降≥5%。我们研究了 EOD 和预测术后(ppo)%DLco 对术后并发症和预后的影响。
共有 106 例(57%)患者被确定为 TFT 阳性,58 例(31%)患者 ppo%DLco<30%。TFT 阳性患者的肺部并发症发生率明显高于 TFT 阴性患者(52%比 19%,P<0.001),多变量分析显示 TFT 阳性是独立的危险因素(比值比 3.46,95%置信区间 1.70-7.07,P<0.001),而 ppo%DLco 不是(P=0.09)。就长期结果而言,TFT 阳性和 ppo%DLco<30%均独立预测总生存率。我们根据 TFT 阳性和 ppo%DLco 状态将患者分为 4 组。TFT 阳性且 ppo%DLco<30%的患者在 4 组中具有最低的 5 年总生存率:ppo%DLco≥30%且 TFT 阴性,54.2%;ppo%DLco<30%且 TFT 阴性,68.8%;ppo%DLco≥30%且 TFT 阳性,38.1%;ppo%DLco<30%且 TFT 阳性,16.7%(P=0.001)。
评估 EOD 有助于预测肺癌和间质性肺疾病患者的术后并发症和生存结局。